Atlas Trials

A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma

Clinical trial NCT03905889 · TERMINATED

Trial details

NCT number
NCT03905889
Sponsor
Brown University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell Carcinoma Metastatic
Start date
2019-06-05
Primary completion
2022-03-08
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.